Skip to main content
. 2019 Mar 31;38(1):108–115. doi: 10.23876/j.krcp.18.0115

Figure 1. Number of participants at screening, run-in period, randomization, and the end of the study.

Figure 1

CVD, cardiovascular disease; HD, hemodialysis; PD, peritoneal dialysis.